Sign In
Buy VERX
$12.98
+0.600 (+4.85%)
At Close: Jul 13, 2026
Vertex to Announce First Quarter 2025 Financial Results on May 5th
04:05pm, Monday, 07'th Apr 2025
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2025 financial results on Monday, May 5, 2025 after the financial markets close. The company w
Vertex's Journavx Launch Sparks Optimism, Analyst Sees 'Two Potential Upside Levers'
12:11pm, Monday, 07'th Apr 2025
Vertex Pharmaceuticals Inc. VRTX is giving investors some good news — especially if they're keeping a close eye on its newly launched painkiller Journavx.
Vertex Announces Program Updates for Type 1 Diabetes Portfolio
04:05pm, Friday, 28'th Mar 2025
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several updates on the Company's type 1 diabetes (T1D) portfolio. VX-264 Update Vertex has completed enrollm
Final Trades: Vertex Pharma, Netflix and the IYF
05:14pm, Thursday, 27'th Mar 2025
The Investment Committee give you their stop stocks to watch for the second half.
Vertex: Expectations Reset With Improved Fundamentals (Rating Upgrade)
08:26am, Wednesday, 26'th Mar 2025
I upgrade my rating for Vertex stock to buy due to the recent valuation pullback, creating an attractive entry point at 7x forward revenue. VERX's cloud growth momentum remains strong, with a 27% y/y
Trade Tracker: Steve Weiss buys Vertex Pharmaceuticals
01:19pm, Monday, 24'th Mar 2025
Steve Weiss, Founder and Managing Partner of Short Hills Capital Partners joins CNBC's “Halftime Report” to explain why he's buying the Pharmaceutical company
As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point
08:00am, Friday, 21'st Mar 2025
Biotech stocks are among the few industry groups producing breakouts and buyable stocks in an uncertain market. Vertex stock is among top biotechs to watch.
Goldman Sachs Analyst Anticipates Clarity On Vertex's Investment Roadmap And Product Monetization At Investor Day
01:45pm, Monday, 17'th Mar 2025
Goldman Sachs analyst Adam Hotchkiss expressed expectations on Vertex, Inc. VERX ahead of its first Investor Day as a public company on March 19.
Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?
11:50am, Monday, 17'th Mar 2025
Those who already own VRTX stock may retain it for some time to see if its CF sales continue to rise and how the Journavx and Alyftrek launch progress.
Vertex, Inc. to Host 2025 Investor Day
04:05pm, Tuesday, 11'th Mar 2025
KING OF PRUSSIA, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) today announced that it will host an Investor Day on Wednesday, March 19, in Philadelphia, PA. The event will featu
LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals (Nasdaq: VRTX) announced today that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for ALYFTREK
Vertex Pharmaceuticals: Company Passes My Health Check With Flying Colors, Upholding Buy Rating
09:00am, Thursday, 06'th Mar 2025
Vertex Pharmaceuticals Incorporated's stock has shown resilience, recovering from dips and maintaining a strong long-term growth trajectory, driven by its robust CF franchise and new product approvals
LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opini
Trade Tracker: Rob Sechan sells McDonald's and Vertex, buys Texas Pacific Land, Amgen and NRG
01:53pm, Thursday, 27'th Feb 2025
Rob Sechan, CEO of NewEdge Wealth, joins CNBC's "Halftime Report" to detail his many portfolio moves.
Vertex, Inc. (VERX) Q4 2024 Earnings Call Transcript
12:29pm, Thursday, 27'th Feb 2025
Vertex, Inc. (NASDAQ:VERX ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Joe Crivelli – Vice President of Investor Relations David DeStefano – President and C
